Healthcare provider profile · identity verified

Khaula Rehman, MD

Internal Medicine · BINGHAMTON, NY · NPI 1568443521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	224
Amlodipine Besylate	Amlodipine Besylate	610	176
Levothyroxine Sodium	Levothyroxine Sodium	599	158
Losartan Potassium	Losartan Potassium	376	118
Lisinopril	Lisinopril	339	96
Metoprolol Succinate	Metoprolol Succinate	328	93
Omeprazole	Omeprazole	323	100
Rosuvastatin Calcium	Rosuvastatin Calcium	291	84
Pantoprazole Sodium	Pantoprazole Sodium	279	88
Simvastatin	Simvastatin	274	74
Metformin Hcl	Metformin Hcl	261	81
Hydrochlorothiazide	Hydrochlorothiazide	254	73
Furosemide	Furosemide	200	71
Fluticasone Propionate	Fluticasone Propionate	165	59
Eliquis	Apixaban	160	47
Clopidogrel	Clopidogrel Bisulfate	147	40
Sertraline Hcl	Sertraline Hcl	146	52
Trazodone Hcl	Trazodone Hcl	145	43
Carvedilol	Carvedilol	129	43
Allopurinol	Allopurinol	128	38
Potassium Chloride	Potassium Chloride	128	36
Alprazolam	Alprazolam	119	26
Metoprolol Tartrate	Metoprolol Tartrate	118	28
Gabapentin	Gabapentin	113	31
Tamsulosin Hcl	Tamsulosin Hcl	101	32
Pravastatin Sodium	Pravastatin Sodium	97	27
Januvia	Sitagliptin Phosphate	78	17
Atenolol	Atenolol	76	23
Synthroid	Levothyroxine Sodium	75	20
Valsartan	Valsartan	75	22
Enalapril Maleate	Enalapril Maleate	73	23
Escitalopram Oxalate	Escitalopram Oxalate	71	24
Albuterol Sulfate Hfa	Albuterol Sulfate	65	36
Jardiance	Empagliflozin	65	19
Spironolactone	Spironolactone	61	19
Citalopram Hbr	Citalopram Hydrobromide	59	12
Venlafaxine Hcl Er	Venlafaxine Hcl	59	19
Zolpidem Tartrate	Zolpidem Tartrate	58	15
Alendronate Sodium	Alendronate Sodium	57	18
Lorazepam	Lorazepam	57	18
Metformin Hcl Er	Metformin Hcl	57	15
Montelukast Sodium	Montelukast Sodium	57	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	56	18
Doxycycline Hyclate	Doxycycline Hyclate	56	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	11
Doxazosin Mesylate	Doxazosin Mesylate	54	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	14
Paroxetine Hcl	Paroxetine Hcl	50	15
Celecoxib	Celecoxib	49	24
Glipizide	Glipizide	49	14
Bupropion Xl	Bupropion Hcl	48	13
Famotidine	Famotidine	48	14
Buspirone Hcl	Buspirone Hcl	47	26
Irbesartan	Irbesartan	41	suppressed
Chlorthalidone	Chlorthalidone	40	11
Finasteride	Finasteride	40	16
Ezetimibe	Ezetimibe	38	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	29
Methylprednisolone	Methylprednisolone	36	33
Lovastatin	Lovastatin	35	suppressed
Amoxicillin	Amoxicillin	32	15
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Cephalexin	Cephalexin	31	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	16
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	12
Hydrocortisone	Hydrocortisone	31	14
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Ramipril	Ramipril	30	13
Xarelto	Rivaroxaban	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Ketoconazole	Ketoconazole	26	16
Labetalol Hcl	Labetalol Hcl	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	14
Nadolol	Nadolol	25	suppressed
Ozempic	Semaglutide	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Rybelsus	Semaglutide	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Naproxen	Naproxen	15	14
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Nystatin	Nystatin	14	11
Pen Needle	Pen Needle, Diabetic	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Armodafinil	Armodafinil	12	suppressed
Lactulose	Lactulose	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Linzess	Linaclotide	12	suppressed
Risperidone	Risperidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	11
Pregabalin	Pregabalin	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error